LOBEF Message Board Post 10638344 | Lobe Sciences Ltd
home / stock / lobef / lobef message board
nap
(investorshangout)
Posted on: Jun/21/2022 14:01:33
Source: investorshangout
https://investorshangout.com/post/view?id=6424898
pennyMoMo: $GTSIF; CSE / $LOBED - Lobe Sciences plans to advance to Phase 1 PTSD study in second half of 2022 w
News, Short Squeeze, Breakout and More Instantly...
Lobe Sciences Ltd Company Name:
LOBEF Stock Symbol:
Market:
-
Welcome to Benzinga's weekly psychedelics headlines roundup. This is our pick of must-read news items from the second week of January 2024.&nbs...
-
12-month data confirming that L-130 is the first reported stable oral psilocin First-in-Man clinical data demonstrates the superior PK profile of L-130 2023 sales of $1.1M (CAD) for Altemia ® Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ("Lobe" or the "Company"...
-
Phase 1 results show significantly increased bioavailability for its stable psilocin compared to psilocybin L-130 Phase 2 Trial Planned for 2024 Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformat...